Literature DB >> 17910071

Classifying protein kinase structures guides use of ligand-selectivity profiles to predict inactive conformations: structure of lck/imatinib complex.

Marc D Jacobs1, Paul R Caron, Brian J Hare.   

Abstract

We report a clustering of public human protein kinase structures based on the conformations of two structural elements, the activation segment and the C-helix, revealing three discrete clusters. One cluster includes kinases in catalytically active conformations. Each of the other clusters contains a distinct inactive conformation. Typically, kinases adopt at most one of the inactive conformations in available X-ray structures, implying that one of the conformations is preferred for many kinases. The classification is consistent with selectivity profiles of several well-characterized kinase inhibitors. We show further that inhibitor selectivity profiles guide kinase classification. For example, selective inhibition of lck among src-family kinases by imatinib (Gleevec) suggests that the relative stabilities of inactive conformations of lck are different from other src-family kinases. We report the X-ray structure of the lck/imatinib complex, confirming that the conformation adopted by lck is distinct from other structurally-characterized src-family kinases and instead resembles kinases abl1 and kit in complex with imatinib. Our classification creates new paths for designing small-molecule inhibitors. 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17910071     DOI: 10.1002/prot.21633

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  27 in total

1.  Effect of the SH3-SH2 domain linker sequence on the structure of Hck kinase.

Authors:  Heike Meiselbach; Heinrich Sticht
Journal:  J Mol Model       Date:  2010-11-26       Impact factor: 1.810

2.  Insights into the conformational flexibility of Bruton's tyrosine kinase from multiple ligand complex structures.

Authors:  Andreas Kuglstatter; April Wong; Stan Tsing; Simon W Lee; Yan Lou; Armando G Villaseñor; J Michael Bradshaw; David Shaw; Jim W Barnett; Michelle F Browner
Journal:  Protein Sci       Date:  2011-02       Impact factor: 6.725

3.  A new screening assay for allosteric inhibitors of cSrc.

Authors:  Jeffrey R Simard; Sabine Klüter; Christian Grütter; Matthäus Getlik; Matthias Rabiller; Haridas B Rode; Daniel Rauh
Journal:  Nat Chem Biol       Date:  2009-04-26       Impact factor: 15.040

4.  Scaffold mining of kinase hinge binders in crystal structure database.

Authors:  Li Xing; Brajesh Rai; Elizabeth A Lunney
Journal:  J Comput Aided Mol Des       Date:  2013-12-29       Impact factor: 3.686

5.  Affinity reagents that target a specific inactive form of protein kinases.

Authors:  Pratistha Ranjitkar; Amanda M Brock; Dustin J Maly
Journal:  Chem Biol       Date:  2010-02-26

6.  An enriched structural kinase database to enable kinome-wide structure-based analyses and drug discovery.

Authors:  Natasja Brooijmans; Yu-Wei Chang; Dominick Mobilio; Rajiah A Denny; Christine Humblet
Journal:  Protein Sci       Date:  2010-04       Impact factor: 6.725

7.  Can structural features of kinase receptors provide clues on selectivity and inhibition? A molecular modeling study.

Authors:  Sarangan Ravichandran; Brian T Luke; Jack R Collins
Journal:  J Mol Graph Model       Date:  2015-01-12       Impact factor: 2.518

8.  Targeted kinase selectivity from kinase profiling data.

Authors:  Francesca Milletti; Johannes C Hermann
Journal:  ACS Med Chem Lett       Date:  2012-03-14       Impact factor: 4.345

9.  Classification of protein kinases on the basis of both kinase and non-kinase regions.

Authors:  Juliette Martin; Krishanpal Anamika; Narayanaswamy Srinivasan
Journal:  PLoS One       Date:  2010-09-15       Impact factor: 3.240

10.  Structural diversity of the active N-terminal kinase domain of p90 ribosomal S6 kinase 2.

Authors:  Margarita Malakhova; Igor Kurinov; Kangdong Liu; Duo Zheng; Igor D'Angelo; Jung-Hyun Shim; Valerie Steinman; Ann M Bode; Zigang Dong
Journal:  PLoS One       Date:  2009-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.